276 related articles for article (PubMed ID: 7033782)
1. Adjusted subcutaneous heparin versus warfarin sodium in the long-term treatment of venous thrombosis.
Hull R; Delmore T; Carter C; Hirsh J; Genton E; Gent M; Turpie G; McLaughlin D
N Engl J Med; 1982 Jan; 306(4):189-94. PubMed ID: 7033782
[TBL] [Abstract][Full Text] [Related]
2. Warfarin sodium versus low-dose heparin in the long-term treatment of venous thrombosis.
Hull R; Delmore T; Genton E; Hirsh J; Gent M; Sackett D; McLoughlin D; Armstrong P
N Engl J Med; 1979 Oct; 301(16):855-8. PubMed ID: 384248
[TBL] [Abstract][Full Text] [Related]
3. Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis.
Hull RD; Raskob GE; Pineo GF; Green D; Trowbridge AA; Elliott CG; Lerner RG; Hall J; Sparling T; Brettell HR
N Engl J Med; 1992 Apr; 326(15):975-82. PubMed ID: 1545850
[TBL] [Abstract][Full Text] [Related]
4. Heparin for 5 days as compared with 10 days in the initial treatment of proximal venous thrombosis.
Hull RD; Raskob GE; Rosenbloom D; Panju AA; Brill-Edwards P; Ginsberg JS; Hirsh J; Martin GJ; Green D
N Engl J Med; 1990 May; 322(18):1260-4. PubMed ID: 2183055
[TBL] [Abstract][Full Text] [Related]
5. A comparison of subcutaneous low-molecular-weight heparin with warfarin sodium for prophylaxis against deep-vein thrombosis after hip or knee implantation.
Hull R; Raskob G; Pineo G; Rosenbloom D; Evans W; Mallory T; Anquist K; Smith F; Hughes G; Green D
N Engl J Med; 1993 Nov; 329(19):1370-6. PubMed ID: 8413432
[TBL] [Abstract][Full Text] [Related]
6. Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis.
Hull R; Hirsh J; Jay R; Carter C; England C; Gent M; Turpie AG; McLoughlin D; Dodd P; Thomas M; Raskob G; Ockelford P
N Engl J Med; 1982 Dec; 307(27):1676-81. PubMed ID: 6755255
[TBL] [Abstract][Full Text] [Related]
7. Optimal therapeutic level of heparin therapy in patients with venous thrombosis.
Hull RD; Raskob GE; Rosenbloom D; Lemaire J; Pineo GF; Baylis B; Ginsberg JS; Panju AA; Brill-Edwards P; Brant R
Arch Intern Med; 1992 Aug; 152(8):1589-95. PubMed ID: 1497392
[TBL] [Abstract][Full Text] [Related]
8. Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis.
Hull RD; Raskob GE; Hirsh J; Jay RM; Leclerc JR; Geerts WH; Rosenbloom D; Sackett DL; Anderson C; Harrison L
N Engl J Med; 1986 Oct; 315(18):1109-14. PubMed ID: 3531862
[TBL] [Abstract][Full Text] [Related]
9. Adjusted versus fixed-dose subcutaneous heparin in the prevention of deep-vein thrombosis after total hip replacement.
Leyvraz PF; Richard J; Bachmann F; Van Melle G; Treyvaud JM; Livio JJ; Candardjis G
N Engl J Med; 1983 Oct; 309(16):954-8. PubMed ID: 6621623
[TBL] [Abstract][Full Text] [Related]
10. Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis.
Levine MN; Hirsh J; Gent M; Turpie AG; Weitz J; Ginsberg J; Geerts W; LeClerc J; Neemeh J; Powers P
Thromb Haemost; 1995 Aug; 74(2):606-11. PubMed ID: 8584992
[TBL] [Abstract][Full Text] [Related]
11. Subcutaneous vs intravenous heparin in the treatment of deep venous thrombosis--a randomized clinical trial.
Pini M; Pattachini C; Quintavalla R; Poli T; Megha A; Tagliaferri A; Manotti C; Dettori AG
Thromb Haemost; 1990 Oct; 64(2):222-6. PubMed ID: 2270531
[TBL] [Abstract][Full Text] [Related]
12. Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study Group.
Koopman MM; Prandoni P; Piovella F; Ockelford PA; Brandjes DP; van der Meer J; Gallus AS; Simonneau G; Chesterman CH; Prins MH
N Engl J Med; 1996 Mar; 334(11):682-7. PubMed ID: 8594426
[TBL] [Abstract][Full Text] [Related]
13. Acenocoumarol and heparin compared with acenocoumarol alone in the initial treatment of proximal-vein thrombosis.
Brandjes DP; Heijboer H; Büller HR; de Rijk M; Jagt H; ten Cate JW
N Engl J Med; 1992 Nov; 327(21):1485-9. PubMed ID: 1406880
[TBL] [Abstract][Full Text] [Related]
14. Subcutaneous adjusted-dose unfractionated heparin vs fixed-dose low-molecular-weight heparin in the initial treatment of venous thromboembolism.
Prandoni P; Carnovali M; Marchiori A;
Arch Intern Med; 2004 May; 164(10):1077-83. PubMed ID: 15159264
[TBL] [Abstract][Full Text] [Related]
15. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
Míka P; Behounek J; Skoták M; Nevsímal L
Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
[TBL] [Abstract][Full Text] [Related]
16. Subcutaneous low-molecular-weight heparin compared with continuous intravenous unfractionated heparin in the treatment of proximal deep vein thrombosis.
Simonneau G; Charbonnier B; Decousus H; Planchon B; Ninet J; Sie P; Silsiguen M; Combe S
Arch Intern Med; 1993 Jul; 153(13):1541-6. PubMed ID: 8391792
[TBL] [Abstract][Full Text] [Related]
17. Low molecular weight heparin (enoxaparin) versus oral anticoagulant therapy (acenocoumarol) in the long-term treatment of deep venous thrombosis in the elderly: a randomized trial.
Veiga F; Escribá A; Maluenda MP; López Rubio M; Margalet I; Lezana A; Gallego J; Ribera JM
Thromb Haemost; 2000 Oct; 84(4):559-64. PubMed ID: 11057850
[TBL] [Abstract][Full Text] [Related]
18. Relation between the time to achieve the lower limit of the APTT therapeutic range and recurrent venous thromboembolism during heparin treatment for deep vein thrombosis.
Hull RD; Raskob GE; Brant RF; Pineo GF; Valentine KA
Arch Intern Med; 1997 Dec 8-22; 157(22):2562-8. PubMed ID: 9531224
[TBL] [Abstract][Full Text] [Related]
19. The importance of initial heparin treatment on long-term clinical outcomes of antithrombotic therapy. The emerging theme of delayed recurrence.
Hull RD; Raskob GE; Brant RF; Pineo GF; Valentine KA
Arch Intern Med; 1997 Nov; 157(20):2317-21. PubMed ID: 9361572
[TBL] [Abstract][Full Text] [Related]
20. Post-operative heparin may not be required for transitioning patients with a HeartMate II left ventricular assist system to long-term warfarin therapy.
Slaughter MS; Naka Y; John R; Boyle A; Conte JV; Russell SD; Aaronson KD; Sundareswaran KS; Farrar DJ; Pagani FD
J Heart Lung Transplant; 2010 Jun; 29(6):616-24. PubMed ID: 20400335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
